Clinical and prognostic significance of positive hepatojugular reflux on discharge in acute heart failure: Insights from the ESCAPE trial

BioMed Research International

Volumn 2017, Issue , 2017, Pages

  Omar, Hesham R ^a   Guglin, Maya ^b  

^a Mercy Medical Center   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ACUTE HEART FAILURE; ADULT; ALL CAUSE MORTALITY; AREA UNDER THE CURVE; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART GRAFT; HEART RIGHT ATRIUM PRESSURE; HEMATOCRIT; HEMODYNAMICS; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPERVOLEMIA; INFERIOR CAVA VEIN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; PHYSICAL EXAMINATION; POSITIVE HEPATOJUGULAR REFLUX; PREDICTIVE VALUE; PROGNOSIS; PULMONARY ARTERY; PULMONARY ARTERY OCCLUSION PRESSURE; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION; ACUTE DISEASE; CLINICAL TRIAL (TOPIC); COMPLICATION; ECHOCARDIOGRAPHY; FACTUAL DATABASE; HEART ATRIUM; HEART FAILURE; HEART FUNCTION TEST; HOSPITAL ADMISSION; HOSPITALIZATION; JUGULAR VEIN; LUNG WEDGE PRESSURE; PATHOLOGY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VASCULAR DISEASE;

ACUTE DISEASE; AREA UNDER CURVE; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART FAILURE; HEART FUNCTION TESTS; HEART VALVE DISEASES; HEMODYNAMICS; HOSPITALIZATION; HUMANS; JUGULAR VEINS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT DISCHARGE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 85017548700     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2017/5734749     Document Type: Article

References (28)

1. A. P. Ambrosy, G. C. Fonarow, J. Butler et al., “The global health and economic burden of hospitalizations for heart failure,” Journal of the American College of Cardiology, vol. 63, no. 12, pp. 1123–1133, 2014.
2. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics—2008 Update: a report from the American heart association statistics committee and stroke statistics subcommittee,” Circulation, vol. 117, no. 4, pp. e25–e46, 2008.
3. H. M. Krumholz, A. R. Merrill, E. M. Schone et al., “Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission,” Circulation: Cardiovascular Quality and Outcomes, vol. 2, no. 5, pp. 407–413, 2009.
4. K. E. Joynt and A. K. Jha, “Who has higher readmission rates for heart failure, and why? implications for efforts to improve care using financial incentives,” Circulation: Cardiovascular Quality and Outcomes, vol. 4, no. 1, pp. 53–59, 2011.
5. S. Chun, J. V. Tu, H. C. Wijeysundera et al., “Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure,” Circulation: Heart Failure, vol. 5, no. 4, pp. 414–421, 2012.
6. C. M. O’Connor, W. G. Stough, D. S. Gallup, V. Hasselblad, and M. Gheorghiade, “Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry,” Journal of Cardiac Failure, vol. 11, no. 3, pp. 200–205, 2005.
7. M. Gheorghiade, G. Filippatos, L. De Luca, and J. Burnett, “Congestion in acute heart failure syndromes: an essential target of evaluation and treatment,” American Journal of Medicine, vol. 119, no. 12, pp. S3–S10, 2006.
8. J. G. F. Cleland, K. Swedberg, F. Follath et al., “The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe: part 1: patient characteristics and diagnosis,” European Heart Journal, vol. 24, no. 5, pp. 442–463, 2003.
9. W. Pasteur, “Note on a new physical sign of tricuspid regurgitation,” The Lancet, vol. 126, no. 3238, 1885.
10. A. S. Maisel, J. E. Atwood, and A. L. Goldberger, “Hepatojugular reflux: useful in the bedside diagnosis of tricuspid regurgitation,” Annals of Internal Medicine, vol. 101, no. 6, pp. 781–782, 1984.
11. R. A. Sochowski, J. D. Dubbin, and S. Z. Naqvi, “Clinical and hemodynamic assessment of the hepatojugular reflux,” The American Journal of Cardiology, vol. 66, no. 12, pp. 1002–1006, 1990.
12. C. Binanay, R. M. Califf, V. Hasselblad et al., “Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial,” The Journal of the American Medical Association, vol. 294, pp. 1625–1633, 2005.
13. S. M. Butman, G. A. Ewy, J. R. Standen, K. B. Kern, and E. Hahn, “Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension,” Journal of the American College of Cardiology, vol. 22, no. 4, pp. 968–974, 1993.
14. J. Wiese, “The abdominojugular reflux sign,” American Journal of Medicine, vol. 109, no. 1, pp. 59–61, 2000.
15. G. A. Ewy, “The abdominojugular test: technique and hemodynamic correlates,” Annals of Internal Medicine, vol. 109, no. 6, pp. 456–460, 1988.
16. P. R. Marantz, M. C. Kaplan, and M. H. Alderman, “Clinical diagnosis of congestive heart failure in patients with acute dyspnea,” Chest, vol. 97, no. 4, pp. 776–781, 1990.
17. F. Besli, M. Kecebas, S. Caliskan, S. Dereli, I. Baran, and Y. Turker, “The utility of inferior vena cava diameter and the degree of inspiratory collapse in patients with systolic heart failure,” American Journal of Emergency Medicine, vol. 33, no. 5, pp. 653–657, 2015.
18. M. H. Drazner, J. E. Rame, L. W. Stevenson, and D. L. Dries, “Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure,” New England Journal of Medicine, vol. 345, no. 8, pp. 574–581, 2001.
19. A. Sachdeva, T. B. Horwich, and G. C. Fonarow, “Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure,” American Journal of Cardiology, vol. 106, no. 6, pp. 830–835, 2010.
20. G. C. Fonarow, L. W. Stevenson, A. E. Steimle et al., “Persistently high left-ventricular filling pressures predict mortality despite angiotensin-converting enzyme-inhibition in advanced heart failure,” Circulation, vol. 90, p. 488, 1994.
21. G. Fonarow, M. Hamilton, J. Moriguchi, J. Creaser, and D. A. Rourke, “Hemodynamic predictors of clinical outcomes in decompensated advanced heart failure,” Journal of Cardiac Failure, vol. 3, article 13, 2001.
22. L. B. Cooper, R. J. Mentz, S. R. Stevens et al., “Hemodynamic predictors of heart failure morbidity and mortality: fluid or flow?” Journal of Cardiac Failure, vol. 22, no. 3, pp. 182–189, 2016.
23. M. Metra, B. Davison, L. Bettari et al., “Is worsening renal function an 338 ominous prognostic sign in patients with acute heart failure? The role of congestion and its 339 interaction with renal function,” Circulation: Heart Failure, vol. 5, pp. 54–62, 2012.
24. S. Mangione, “Cardiac auscultatory skills of physicians-in-training: a comparison of three english-speaking countries,” American Journal of Medicine, vol. 110, no. 3, pp. 210–216, 2001.
25. S. Mangione and L. Z. Nieman, “Cardiac auscultatory skills of internal medicine and family practice trainees: a comparison of diagnostic proficiency,” JAMA, vol. 278, no. 9, pp. 717–722, 1997.
26. J. E. Rame, D. L. Dries, and M. H. Drazner, “The prognostic value of the physical examination in patients with chronic heart failure,” Congestive Heart Failure, vol. 9, no. 3, pp. 170–178, 2003.
27. M. H. Drazner, A. S. Hellkamp, C. V. Leier et al., “Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial,” Circulation. Heart failure, vol. 1, no. 3, pp. 170–177, 2008.
28. C. V. Leier and K. Chatterjee, “The physical examination in heart failure—Part II,” Congestive Heart Failure, vol. 13, no. 2, pp. 99–104, 2007.